Moving Beyond Mutation - AI-driven Functional Precision Medicine for Cancer

Explore a groundbreaking webinar on AI-driven functional precision medicine for cancer presented by Dr. Sungwon Lim, a bioengineer and entrepreneur with extensive experience in academia, pharmaceuticals, and biotech. Discover how ImpriMed's innovative approach combines live-cell-based ex vivo drug sensitivity assays, immune profiling, blood work, and genotyping with AI algorithms to predict anticancer drug efficacy and evaluate prognosis. Learn about the potential of this precision medicine platform to reduce treatment burden and enhance clinical outcomes for cancer patients. Gain insights into the basic concepts of AI and machine learning-based predictive models and their powerful applications in improving cancer treatment outcomes. This 35-minute presentation offers a comprehensive look at the future of personalized cancer treatment, moving beyond mutation analysis to a more holistic approach in functional precision medicine.